Mucin-mediated nanocarrier disassembly for triggered uptake of oligonucleotides as a delivery strategy for the potential treatment of mucosal tumours

Antisense oligonucleotides in cancer

(2014) Daniela Castanotto et al.   CURRENT OPINION IN ONCOLOGY

Mucus barrier-triggered disassembly of siRNA nanocarriers

(2014) Troels B. Thomsen et al.   Nanoscale

RNAi Therapies: Drugging the Undruggable

(2014) S. Y. Wu et al.   Science Translational Medicine

Nanoparticle-Mediated Systemic Delivery of siRNA for Treatment of Cancers and Viral Infections

(2014) Mohamed Shehata Draz et al.   Theranostics

Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic

(2014) Pedro M. D. Moreno et al.   Frontiers in Chemistry

RNA Interference in the Treatment of Colon Cancer

(2013) Jose Prados et al.   BIODRUGS

Polycation-based nanoparticles for RNAi-mediated cancer treatment

(2013) Borja Ballarín-González et al.   CANCER LETTERS

PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease

(2013) Christian Lautenschläger et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

In vitrotoxicity assessment of silver nanoparticles in the presence of phenolic compounds – preventive agents against the harmful effect?

(2013) Alina Martirosyan et al.   Nanotoxicology

MUC1 and metastatic cancer

(2013) Teresa M. Horm et al.   Cell Adhesion & Migration

Sensitive pH probes of retro-self-quenching fluorescent nanoparticles

(2013) Lin-Chen Ho et al.   Journal of Materials Chemistry B

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles

(2013) Borja Ballarín-González et al.   Molecular Therapy-Nucleic Acids

The application of RNAi-based treatments for inflammatory bowel disease

(2013) Morten Tobias Jarlstad Olesen et al.   Drug Delivery and Translational Research

Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery

(2012) Laura M. Ensign et al.   ADVANCED MATERIALS

Mucin-based Targeted Pancreatic Cancer Therapy

(2012) Maria P. Torres et al.   CURRENT PHARMACEUTICAL DESIGN

Nanoparticle-based clodronate delivery mitigates murine experimental colitis

(2012) Wiebke Niebel et al.   JOURNAL OF CONTROLLED RELEASE

Multicolored pH-Tunable and Activatable Fluorescence Nanoplatform Responsive to Physiologic pH Stimuli

(2012) Kejin Zhou et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Uptake, Efficacy, and Systemic Distribution of Naked, Inhaled Short Interfering RNA (siRNA) and Locked Nucleic Acid (LNA) Antisense

(2011) Sterghios A Moschos et al.   MOLECULAR THERAPY

Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines

(2010) D. Scott Wilson et al.   NATURE MATERIALS

Pulmonary Gene Silencing in Transgenic EGFP Mice Using Aerosolised Chitosan/siRNA Nanoparticles

(2010) Ebbe J. B. Nielsen et al.   PHARMACEUTICAL RESEARCH

Delivery of RNA interference therapeutics using polycation-based nanoparticles

(2009) Kenneth Alan Howard   ADVANCED DRUG DELIVERY REVIEWS

Micro- and macrorheology of mucus

(2009) Samuel K. Lai et al.   ADVANCED DRUG DELIVERY REVIEWS

Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents

(2009) C. A. Stein et al.   NUCLEIC ACIDS RESEARCH

Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability☆

(2008) Gretchen J. Mahler et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells

(2008) Hanne B. Moeller et al.   KIDNEY INTERNATIONAL

Mucins in the mucosal barrier to infection

(2008) S K Linden et al.   Mucosal Immunology